Trials / Unknown
UnknownNCT03346824
Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Failure of Weaning from ECMO is a serious complication, reaching an incidence between 29 and 58%. Inotrops are frequently used to help separating patient from ECMO. Levosimendan is an ino-dilatatory medication and was used in different clinical settings. The aim of this study was to evaluate the benefit with levosimendan when used in weaning process.
Conditions
Timeline
- Start date
- 2017-11-15
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2017-11-17
- Last updated
- 2018-02-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03346824. Inclusion in this directory is not an endorsement.